Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
BeiGene
BeiGene
Eastern Cooperative Oncology Group
University of Colorado, Denver
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Fox Chase Cancer Center
Case Comprehensive Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
Swiss Cancer Institute